从非洲地区对COVID-19应对措施的参与性评估中吸取的一些教训
Peter Phori1, Stephen Fawcett2, Noemie Nikiema Nidjergou1
1World Health Organization Regional Office for Africa, Brazzaville, Congo.
Health promotion practice
|January 2, 2025
概括
本报告审查了非洲COVID-19大流行病的反应,确定了减少或增加病例的因素. 它强调了响应实施的推动因素和障碍,为未来的公共卫生紧急情况提供了教训.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 卫生政策 卫生政策
背景情况:
- 在全球范围内,COVID-19大流行给公共卫生系统带来了前所未有的挑战.
- 有效的应对策略在不同地区有所不同,需要本地化理解和适应.
- 在疫情期间,非洲地区面临着独特的社会经济和医疗保健系统限制.
研究的目的:
- 记录和分析合作伙伴在选定的非洲国家对COVID-19应对工作的经验和反思.
- 确定与COVID-19病例减少和增加相关的因素.
- 确定疫情期间使公共卫生干预措施实施成为可能或阻碍的因素.
主要方法:
- 采用了参与式评价和感知制造的共同协议.
- 数据收集涉及加,肯尼亚和塞内加尔的合作伙伴国家.
- 从世界卫生组织非洲区域办事处 (WHO AFRO) 的合作伙伴那里收集了区域视角.
主要成果:
- 确定了与COVID-19病例减少相关的因素 ("曲线曲").
- 确定了与COVID-19病例增加 ("恶化") 相关的因素.
- 记录了国家和区域一级响应实施的关键推动因素和障碍.
结论:
- 从非洲地区的COVID-19反应中吸取的经验教训.
- 改善未来公共卫生应急准备和应对的建议.
- 强调了特定环境策略和公共卫生危机适应性管理的重要性.
相关概念视频
01:18Steps in Outbreak Investigation
105
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
105
01:26Principles of Disease Surveillance
69
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
69
01:20Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K
01:30Community Based Intervention
33
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
33
01:15Nursing Evaluation
3.2K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.2K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
139
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
139